Sign Up Now to Download a Free Research Report on PTIE

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Pain Therapeutics

Pain Therapeutics shares plunged 49.62 percent on volume of over 5.0 million shares traded Friday to close at $2.68 a share. Shares of the company and Durect Corp. fell sharply after Pfizer Inc. stated it was reassessing partnership for the painkiller Remoxy. “Given the years of delay, additional cost incurred to bring the program to this point and development work left in the program, there will be much to consider,” Pfizer said in a letter.

Going forward ... (see research report)



RESEARCH REPORT ON PTIE Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on